The insulin-sensitizer agonist, PPAR-γ, stimulates adiponectin production, which in turn decreases hepatic steatosis by activating AMP-activated protein kinase, enhancing insulin sensitivity [14]. This evidence concerns the gene INS and fatty liver disease.